Israel Pharmaceuticals and Healthcare Report Q2 2014

Business Monitor International
March 19, 2014
141 Pages - SKU: BMI5217969
Countries covered: Israel

Israel Pharmaceuticals and Healthcare Report Q2 2014

BMI View: Israel's pharmaceutical industry is well developed and export-driven. It is also a very attractiveprospect for multinationals looking to launch innovative medicines due to a greater need for specialtytreatments, thereby capitalising on the country's strong academic research infrastructure. Favourablefactors include high per capita spending on medicines, a market size approaching US$2bn, a highproportion of pensioners and a largely urbanised population. However, we caution that poor patent respectand a lack of business transparency remain key threats to company revenues. Additionally, we hold arelatively less optimistic outlook for growth in the market, based on weaker private consumption over themedium term.

Headline Expenditure Projections

Pharmaceuticals: ILS7.31bn (US$2.02bn) in 2013 to ILS7.48bn (US$2.11bn) in 2014; +2.4% in localcurrency terms and 4.4% in US dollar terms. Forecast remains broadly in line with Q114.

Healthcare: ILS73.59bn (US$20.39bn) in 2013 to ILS78.32bn (US$22.12bn) in 2014; +6.4% in localcurrency terms and 8.5% in US dollar terms. Forecast lower than in Q114 due to impact of austeritymeasures.



More Prescription Drugs reports by Business Monitor International

Venezuela Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Venezuela Pharmaceuticals and Healthcare Report Q4 2014BMI View: Venezuela's improving foreign currency supply, increasing pharmaceutical imports frompolitical allies and the potential expansion of free medicine ...
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescriptionnumbers, does not come ...
Switzerland Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Switzerland Pharmaceuticals and Healthcare Report Q4 2014BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increasedpharmaceutical and healthcare spending. The proportion of ...
Qatar Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Qatar Pharmaceuticals and Healthcare Report Q4 2014BMI View: The reduction of a large number of medicine prices in Qatar is likely to be detrimental topharmaceutical ...
See all reports like this >>

More Israel Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Israel Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Israel Q4 2014BMI View: Even though Israel's tense domestic and external situation threatens overall market stability, itspharmaceutical industry remains well ...
The Pharmaceutical Market: Israel by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: Israel (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

More Israel reports

D&B Country Report: Israel by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!